Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

December 2020 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In December 2020, FDA received 126,896 drug adverse event reports. In December 2019, FDA received 124,534.

In December 2020, FDA received 178,103 medical device reports. In December 2019, FDA received 144,493.

By drug reports received, December 2020 was number 3 of the 12 months of 2020. FDA received 121,063 drug reports a month on average in the 12 months before December 2020.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to December 2020
0100,000200,000201820192020

Drugs in the reports

The table has the 141 drug pages with 250 or more reports in December 2020. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of December 2020 name as a suspect product, in order of name
DrugReports in the month
Actemra690
Aimovig525
Albuterol sulfate648
Alprazolam343
Amlodipine323
Apixaban1,081
Arava363
Aspirin265
Atorvastatin352
Azithromycin Anhydrous355
Bamlanivimab931
Bethkis250
Buprenorphine Transdermal Patch371
Butrans468
Capecitabine291
Carboplatin609
Cimzia341
Cisplatin326
Clopidogrel291
Clozapine362
Cosentyx1,568
Cyclophosphamide789
Cytarabine332
Dexamethasone905
Diazepam407
Diclofenac sodium567
Dilaudid1,777
Docetaxel347
Doxorubicin330
Duodopa289
Dupixent1,915
Eligard432
Eliquis1,066
Emgality496
Enbrel1,415
Entresto1,038
Epidiolex294
Etoposide401
Eylea1,649
Fentanyl576
Fluorouracil264
Furosemide410
Gabapentin406
Gilenya446
Heroin274
Humalog357
Humira2,511
Hydrocodone bitartrate407
Hydrocodone bitartrate and acetaminophen1,964
Hydromorphone Tablets358
Hydroxychloroquine815
Hydroxychloroquine sulfate424
Hysingla ER305
Ibrance943
Ibuprofen485
Imbruvica2,070
Inbrija392
Ingrezza406
Insulin glargine252
Jakafi490
Keytruda405
Lamotrigine287
Leflunomide521
Letrozole275
Levetiracetam361
Lyrica439
Metformin598
Metformin hydrochloride275
Methadone425
Methotrexate1,651
Methotrexate sodium404
Methylprednisolone553
Mirena516
Mirtazapine284
Morphine sulfate1,157
MS Contin1,132
Mycophenolate mofetil925
Myorisan350
Neulasta908
Nexium278
Nexplanon285
Nivolumab515
Nuplazid358
Nurtec Odt314
Ocrevus410
Olanzapine329
Omeprazole487
Opdivo411
Orencia953
Otezla959
Oxaliplatin311
Oxbryta833
Oxycodone253
Oxycodone and acetaminophen1,762
Oxycodone hydrochloride3,620
OxyContin4,435
Oxyir376
Paclitaxel351
Pantoprazole422
Paracetamol704
ParaGard T 380A3,128
Percocet645
Pomalyst1,033
Prednisolone809
Prednisone1,409
Pregabalin315
Prolia579
Quetiapine374
Ranitidine1,011
Ranitidine hydrochloride296
Remdesivir264
Remicade946
Remodulin253
Repatha734
Revlimid4,074
Rinvoq343
Rituximab1,909
Rubraca979
Sertraline384
Simponi516
Stelara940
Sulfasalazine487
Symbicort297
Tacrolimus868
Tagrisso294
Tecfidera694
Tramadol1,077
Trulicity766
Truvada280
Tysabri303
Vancomycin301
Vedolizumab968
Venclexta341
Vicodin361
Vincristine329
Voltaren Arthritis Pain388
Xarelto506
Xeljanz1,748
Xiaflex502
Zantac3,762
Zytiga268

Reaction terms in the reports

The table has the 61 reaction terms with 1,000 or more reports in December 2020. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of December 2020 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort1,059
Abdominal painstomach or belly pain1,522
Abdominal pain upperupper stomach pain1,174
Acute kidney injurysudden loss of kidney function1,422
Alopeciahair loss1,185
Anaemialow red blood cells1,053
Anxietyanxiety1,661
Arthralgiajoint pain2,323
Astheniaweakness or lack of energy2,086
Back painback pain1,259
Condition aggravatedthe condition being treated got worse1,884
Constipationconstipation1,393
Coughcough1,684
Covid-19COVID-19 infection3,026
Deaththe patient died; cause not stated by this term8,585
Decreased appetitereduced appetite1,250
Depressionlow mood1,251
Device expulsionthe device came out1,263
Diarrhoealoose or frequent stools4,066
Dizzinesslight-headedness or unsteadiness2,403
Drug dependencedependence on a medicine5,233
Drug hypersensitivityan allergic-type reaction (the term names a medicine)1,315
Drug ineffectivethe medicine did not work as expected8,555
Drug withdrawal syndromesymptoms on stopping a medicine1,176
Dyspnoeashortness of breath3,125
Erythemaskin redness1,114
Falla fall1,886
Fatiguetiredness4,604
Feeling abnormalfeeling odd or not right1,257
Foetal exposure during pregnancythe unborn baby was exposed to the medicine1,175
Headachehead pain3,472
Hospitalisationadmission to hospital1,142
Hypersensitivityan allergic-type reaction1,066
Hypertensionhigh blood pressure1,160
Hypotensionlow blood pressure1,113
Illness1,197
Inappropriate schedule of product administrationthe product was taken at the wrong times1,617
Incorrect dose administeredthe wrong dose was given1,052
Injection site painpain where the injection was given1,205
Insomniadifficulty sleeping1,353
Intentional product use issuedeliberate use not as intended1,031
Malaisegeneral feeling of being unwell2,061
Nauseafeeling sick4,376
Off label useused for a purpose or in a way not on the label7,034
Overdosea dose above the recommended amount3,746
Painpain, site not specified3,904
Pain in extremitypain in an arm or leg1,508
Peripheral swellingswelling of the arms or legs1,102
Pneumonialung infection1,683
Product dose omission issuea dose was missed4,256
Product use in unapproved indicationused for a purpose not on the label1,879
Product use issuea problem in how the product was used1,150
Pruritusitching1,921
Pyrexiafever2,044
Rashskin rash2,498
Somnolencedrowsiness1,168
Toxicity to various agentspoisoning or toxic effect of one or more substances1,525
Vomitingbeing sick2,471
Weight decreasedweight loss1,725
Weight increasedweight gain1,192
Wrong technique in product usage processthe product was used in the wrong way1,330

Devices in the reports

The table has the 57 device pages with 250 or more reports in December 2020. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of December 2020 name, in order of name
Brand nameReports in the month
630G Insulin PUMP MMT-1715K 630G BLACK MG948
630G Insulin PUMP MMT-1715KL 630G372
640G Insulin Pump MMT-1711K835
640G Insulin Pump MMT-1712K1,507
670G Insulin Pump MMT-1780KL1,067
8015 Alaris System Pc Unit6,200
8100 Alaris Pump Module13,271
8110 Alaris Syringe Pump3,890
8120 Alaris Pca1,148
8300 Alaris Etco2 Module1,087
Alaris Pc Unit444
Alaris Pump Module4,755
Alaris System Pc Unit1,789
Biohorizons Dental Implant805
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim348
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP288
Cadd287
CapSureFix Novus Lead MRI SureScan1,028
Cobas Sars-Cov-2 Test406
Dexcom G5 Mobile Continuous Glucose Monitoring System608
Dexcom G6 Continuous Glucose Monitoring System28,360
Essure308
Freestyle Libre 14 Day280
HeartWare Ventricular Assist System - Pump336
Implantable Collamer Lens Icl467
Inspira Smooth Silicone Gel Filled Breast Implant305
Inspira Textured Silicone Gel Filled Breast Implant349
Intellis297
Legacy 3 Implant279
Libre 2 Sensor FreeStyle320
Libre Sensor Freestyle896
LifeVest WCD 4000 System1,020
MENTOR MemoryGel Breast Implant645
Neo Meter Optium FreeStyle262
Ni264
NobelActive Internal RP 4.3x10mm434
NobelActive Internal RP 4.3x11.5mm384
NobelActive Internal RP 4.3x13mm324
NobelParallel CC RP 4.3x10mm392
NobelParallel CC RP 4.3x11.5mm275
NobelReplace CC RP 4.3x10mm324
Octrode Lead Kit, 60cm Length387
Omnipod DASH Insulin Management System563
Omnipod Insulin Management System1,020
Perclose Proglide 6f Suture Mediated Closure Smc System382
Pump MMT-1780KPK 670G Pathway Black MG3,031
Pump Mmt-1782k 670g V4 11 Mm387
Spectrum Infusion Pump393
Sprint Quattro Secure S MRI SureScan312
Style 68 Saline Filled Breast Implant319
T Slim G5 System467
t:slim X2 Insulin Pump412
t:slim X2 Insulin Pump with Basal-IQ Technology2,419
t:slim X2 Insulin Pump with Control-IQ Technology4,989
Tendril Sts486
Unknown Implant407
V60 Ventilator471

Cite this page

Reported Reactions. December 2020: adverse event reports received by FDA. https://reportedreactions.com/month/2020-12/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for December 2020 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 126,896 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.